News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor

Breast Density Advocate Nancy M. Cappello Passes Away

Cappello’s work to inform women about the risks of dense breast tissue led to density inform laws in 35 states

Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

November 15, 2018 — Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who could be called the founder of the breast density education movement in the U.S., on her passing on Nov. 15. A breast cancer survivor herself, Cappello passed away from secondary myelodyspastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments.

Cappello was diagnosed with stage 3C breast cancer in February 2004, just six weeks after her annual mammogram came up normal. Her doctor told her that the cancer was missed on the mammogram because she had dense fibroglandular breast tissue, a concept that was little-known among patients at that time. Dense breast tissue appears white on a traditional 2-D mammogram, which can mask cancers that also show up as white. Women with extremely dense breast tissue are five times more likely to have breast cancer compared to women with fatty breasts. 

Wanting to make sure other women had access to this critical information to make more informed decisions about their healthcare, Cappello founded the nonprofit organizations Are You Dense Inc. and Are You Dense Advocacy in 2008. The group’s aims are four-fold:

  1. Educate the public about breast health and the impact of dense breast tissue
  2. Improve the condition of those diagnosed with breast cancer through education
  3. Advocate changes to public policy about the prevention and treatment of breast cancer, including breast cancer screening guidelines
  4. Support new and existing research about the prevention and treatment of breast cancer and the causal and screening risks of dense breast tissue and its impact on advanced disease

One of the group’s most visible efforts has been working with state legislatures to enact laws requiring mammography facilities to inform patients about their breast density and the associated cancer risks. Cappello started with the legislature in her home state of Connecticut, playing an instrumental part in the passage of the first breast density inform law in 2009. Since then, 36 states have passed some form of density notification legislation, with others in progress. Are You Dense and Are You Dense Advocacy have also been working with Congress to enact a national density inform law that would allow greater standardization among the states.  

Cappello’s latest medical battles began in September, according to her own blog post on AreYouDense.org. She was admitted to the hospital after feeling increasingly weak, to the point where she could not stand or walk for more than 1 minute without sitting down. Three weeks later, the diagnosis of secondary MDS was confirmed following a bone marrow biopsy. She had been awaiting a bone marrow transplant after it was determined none of her three siblings were a match.

“I am on a quest to expose this best-kept secret of dense breast tissue to ensure that women with dense breast tissue receive screening and diagnostic measures to find cancer at its earliest stage — isn’t that the purpose of screening programs?” she wrote on the AreYouDense website.

"Nancy was the originator of the dense breast tissue movement starting in Connecticut then across the nation and around the world. We believe she alone and the legislation she helped craft in 36 states has saved many lives," said Donna Johnson, president of Are You Dense Inc. in a statement. "Nancy's work is not over. Are You Dense Inc. and Are You Dense Advocacy Inc. will continue to work on a national breast density notification law and work on the remaining states one by one."

“Nancy Cappello was the inspiration behind the first #BreastDensity legislation in Connecticut in 2009. She will continue to inspire us to question the status quo and strive to do better,” said Wendy Ingman, Ph.D., associate professor in breast biology and cancer at the University of Adelaide, Australia, on Twitter.

“We lost Nancy Cappello, founder of RU Dense, today due to complications related to treatment of bc [breast cancer]. A brave woman whose actions truly made a difference!” said Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre, and professor of medical biophysics and medical imaging, University of Toronto.

Click through the links below to see ITNtv interviews with Cappello, as well as pieces she contributed to the magazine.

VIDEO: The Impact of Breast Density Technology and Legislation

VIDEO: Personalized Breast Screening and Breast Density

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference

Fake News: Having Dense Breast Tissue is No Big Deal

The Manic World of Social Media and Breast Cancer: Gratitude and Grief

Related Content

News | Breast Imaging | September 20, 2021
September 20, 2021 — ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of...
This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of TriVu ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
While the Mammography Quality Standards Act (MQSA) and the introduction of EQUIP (Enhancing Quality Using the Inspection Program) have been successful in standardizing and enhancing mammographic imaging quality, inadequate breast positioning can dramatically impact the ability of radiologists and technicians to quickly and accurately detect breast cancer and potentially malignant lesions in their patients

Getty Images

Feature | Mammography | September 15, 2021 | By Christopher Austin, M.D. and Randy D. Hicks, M.D., MBA
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
According to ARRS’ American Journal of Roentgenology (AJR), immediately reading screening mammograms during the coronavirus disease (COVID-19) pandemic promises a new and improved paradigm—reducing care disparities, while increasing the speed of diagnostic workup.

Flow Chart of Patient Selection

News | Breast Imaging | September 09, 2021
September 9, 202
Laws designed to help women with increased risk for missed breast cancer diagnoses may help catch the disease earlier, according to Penn State College of Medicine researchers.

Getty Images | AleksandarNakic

News | Breast Imaging | September 09, 2021
September 9, 2021 — Laws designed to help women with increased risk for...
The researchers say there is currently a lack of good quality evidence to support a policy of replacing human radiologists with artificial intelligence (AI) technology when screening for breast cancer.

Getty Images

News | Artificial Intelligence | September 02, 2021
September 2, 2021 — Humans still seem to be better than technology when it comes to the accuracy of spotting possible
Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy to treat breast cancer, researchers are now exploring the potential integration of CDK inhibitors with radiotherapy

Schematic overview of cell cycle regulation, with an emphasis on radiotherapy-induced pathways and CDK/cyclin regulation. In M phase and in G2 resting phase, cancer cells are respectively very sensitive and moderately sensitive to radiation injury, whereas in G1 phase and in S phase, cancer cells are moderately resistant to radiation injury. Irradiation induces G1 and G2 cell cycle checkpoint activation and DNA repair. Most cancer cells are defective in G1 checkpoint, commonly due to the mutations/alterations of the key regulators of the G1 checkpoint, but contain a functional G2 checkpoint. Figure courtesy of The International Journal of Molecular Sciences

News | Radiation Therapy | August 18, 2021
August 18, 2021 — Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy t